@prefix biolink: . @prefix ns1: . @prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix dct: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { biolink:category biolink:Disease . sub:association rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; rdfs:label "\"Doxercalciferol is contraindicated in patients with: Hypercalcemia [see Warnings and Precautions (5.1) Vitamin D toxicity [see Warnings and Precautions (5.1) Known hypersensitivity to doxercalciferol or any of the inactive ingredients of Doxercalciferol capsules or HECTOROL injection; serious hypersensitivity reactions including anaphylaxis and angioedema have been reported [see Warnings and Precautions (5.3) Adverse Reactions (6.2) Hypercalcemia ( 4 Vitamin D toxicity ( 4 Know hypersensitivity to doxercalciferol or any of the inactive ingredients of Doxercalciferol capsules or HECTOROL injection ( 4\""; biolink:provided_by ; biolink:relation schema:MedicalContraindication . biolink:category biolink:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "ZzrzNhXi04iIg0IB1vIMUL0q1AhPueZQZ3MQwbLwYRq8Pp9ekqSC8YtFWCHQjo+mlWQ4PRlI6Qp8tMBfY2QvTaywSutEZW+ndvBRbBew4ojfn2y7NUQbAsOQ+q6aJa2toAnvwtpxBki26iKE98IEq+KR5cheQ6zhJEnGd9XPFlQ="; npx:hasSignatureTarget this: . this: dct:created "2021-08-25T13:55:35.064+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; ns1:wasCreatedFromProvenanceTemplate ; ns1:wasCreatedFromPubinfoTemplate ; ns1:wasCreatedFromTemplate . }